Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test

The FDA approved the second comprehensive “liquid biopsy” platform that can detect multiple kinds of cancer from tumor DNA circulating in a patient’s blood.

Read the full article here

Related Articles